THE INFLUENCE OF GROWTH OPPORTUNITIES, CAPITAL STRUCTURE, PROFITABILITY, AND DIVIDEND POLICY ON FIRM VALUE (In Pharmaceutical Companies Listed on the Indonesia Stock Exchange 2014-2022)

Lilin Marsiati, Pristin Prima Sari, R. Kusumawardhani
{"title":"THE INFLUENCE OF GROWTH OPPORTUNITIES, CAPITAL STRUCTURE, PROFITABILITY, AND DIVIDEND POLICY ON FIRM VALUE (In Pharmaceutical Companies Listed on the Indonesia Stock Exchange 2014-2022)","authors":"Lilin Marsiati, Pristin Prima Sari, R. Kusumawardhani","doi":"10.36987/ecobi.v11i1.5381","DOIUrl":null,"url":null,"abstract":"This research aims to see the influence of growth opportunities, capital structure, profitability and dividend policy on company value. The type and source of research data is quantitative data using financial reports on pharmaceutical companies listed on the IDX for 2014-2022, while the sampling technique uses purposive sampling to obtain 9 pharmaceutical companies that meet the criteria. The method used in this research is multiple linear regression analysis, using the SPSS program to test it. The results show that partially growth opportunities (PER) and profitability (ROA) have a positive and significant effect on company value. Capital Structure (DER) has a negative but significant effect on company value. Dividend Policy (DPR) has a negative and insignificant effect on company value. Meanwhile, simultaneously the results of the F test and the coefficient of determination test show that X1, X2, X3, and X4 have a simultaneous effect on Y.","PeriodicalId":309702,"journal":{"name":"ECOBISMA (JURNAL EKONOMI, BISNIS DAN MANAJEMEN)","volume":" 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ECOBISMA (JURNAL EKONOMI, BISNIS DAN MANAJEMEN)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36987/ecobi.v11i1.5381","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This research aims to see the influence of growth opportunities, capital structure, profitability and dividend policy on company value. The type and source of research data is quantitative data using financial reports on pharmaceutical companies listed on the IDX for 2014-2022, while the sampling technique uses purposive sampling to obtain 9 pharmaceutical companies that meet the criteria. The method used in this research is multiple linear regression analysis, using the SPSS program to test it. The results show that partially growth opportunities (PER) and profitability (ROA) have a positive and significant effect on company value. Capital Structure (DER) has a negative but significant effect on company value. Dividend Policy (DPR) has a negative and insignificant effect on company value. Meanwhile, simultaneously the results of the F test and the coefficient of determination test show that X1, X2, X3, and X4 have a simultaneous effect on Y.
增长机会、资本结构、盈利能力和股利政策对公司价值的影响(2014-2022 年印尼证券交易所上市的制药公司)
本研究旨在了解增长机会、资本结构、盈利能力和分红政策对公司价值的影响。研究数据的类型和来源为定量数据,使用 2014-2022 年 IDX 上市医药公司的财务报告,抽样技术使用目的性抽样,获得 9 家符合标准的医药公司。本研究采用的方法是多元线性回归分析,使用 SPSS 程序进行检验。结果表明,部分增长机会(PER)和盈利能力(ROA)对公司价值有显著的正向影响。资本结构(DER)对公司价值有负向但显著的影响。股利政策(DPR)对公司价值的影响为负且不显著。同时,F 检验和决定系数检验的结果表明,X1、X2、X3 和 X4 同时对 Y 有影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信